The next generation of cancer care depends on a research process that takes an average of 12 years. If cell and animal laboratory tests suggest a new treatment or drug would be safe and effective, it moves on to clinical trials, the first studies involving humans.
The National Cancer Institute (NCI) funds many cancer clinical trials. Actual research is run by NCI-sponsored cancer cooperative groups ― networks of physicians and institutions specializing in a particular aspect of cancer. Since 2000, 21 St. Mary's radiation oncology patients have participated in seven clinical trials studying prostate, lung, rectal, and other cancers by the NCI-sponsored Radiation Therapy Oncology Group (RTOG).
The American Cancer Society estimates only four percent of adults with cancer take part in clinical trials. Unfortunately, low participation in a clinical trial can mean the study is canceled and a promising treatment not tested. Many patients say they didn't know they were eligible for a study.
The American Cancer Society's website, http://www.cancer.org, is an excellent source of patient information on clinical trials, including factors to consider in deciding to participate.